Divisions of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, Mass; Department of Vascular Surgery, University Medical Center, Utrecht, The Netherlands.
Divisions of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, Mass.
J Vasc Surg. 2022 Feb;75(2):526-534. doi: 10.1016/j.jvs.2021.08.068. Epub 2021 Oct 6.
Compliance with Society for Vascular Surgery (SVS) abdominal aortic aneurysm (AAA) clinical practice guideline (CPG)-diameter thresholds is variable for endovascular aneurysm repair (EVAR). To evaluate the implications and appropriateness of repairs that are noncompliant with current guidelines, we investigated the long-term outcomes, adherence to imaging follow-up, and associated health care costs in patients undergoing EVAR for AAA who do or do not meet recommended diameter thresholds.
All patients receiving elective EVAR from 2003 to 2016 in the SVS Vascular Quality Initiative with linked Medicare claims were reviewed. Weekend procedures and isolated iliac aneurysms, as well as symptomatic and ruptured presentations, were excluded. Diameter thresholds for noncompliant repairs were defined as: men <55 mm; women <50 mm who did not have an iliac diameter ≥30 mm. We evaluated adherence to postoperative imaging surveillance, reimbursement amounts, reintervention, rupture, and all-cause mortality. We defined an EVAR quality metric as performance of the index procedure with freedom from conversion to open repair, 5-year rupture-free survival, and adherence to minimum imaging surveillance (at least one computed tomography scan documented between 6 and 24 months postoperatively).
Among 19,018 elective EVARs, 35% did not meet CPG diameter thresholds (26% within 5 mm of threshold). The rate of noncompliant repairs increased over time (24% in 2003 vs 36% in 2016; P < .001). Patients undergoing noncompliant repairs were younger, less likely to have multiple comorbidities, and more likely to receive EVAR with adherence to instructions for use criteria (89% vs 79%; P < .001). Patients undergoing noncompliant repairs had greater 5-year freedom from reintervention (86% vs 81%; P < .001), rupture-free survival (94% vs 92%; P = .01), and overall survival rates (71% vs 61%; P < .001) compared with repairs that complied with CPG diameter thresholds. Although noncompliant repairs had higher rates of 1-year imaging surveillance, overall differences were modest (68% vs 65%; P = .003). Importantly, for the entire cohort, follow-up imaging surveillance decreased over time (93% in 2003 vs 63% in 2014; P < .001). Notably, although noncompliant repairs had higher rates of achieving the composite quality metric compared with compliant repairs (43% vs 38%; P < .001), failure occurred with a significant majority of all repairs.
Compliance with SVS-endorsed CPG diameter thresholds for elective EVAR is poor, and rates of noncompliance are increasing. Noncompliant repairs appear to be offered more commonly to patients with fewer comorbidities and favorable anatomy, and these repairs are associated with improved rates of reintervention, rupture, and survival compared with procedures meeting CPG diameter thresholds. Importantly, noncompliant repairs fail to meet minimum quality standards in a majority of cases, which underscores the need for further policies to improve the overall quality and appropriateness of AAA care delivery nationally.
血管外科学会(SVS)腹主动脉瘤(AAA)临床实践指南(CPG)直径阈值在血管内修复术(EVAR)中的符合率存在差异。为了评估不符合当前指南的修复的影响和适当性,我们研究了不符合推荐直径阈值的接受 EVAR 治疗的 AAA 患者的长期结果、对影像学随访的依从性以及相关的医疗保健费用。
回顾了 2003 年至 2016 年期间在 SVS 血管质量倡议中接受择期 EVAR 并与医疗保险索赔相关联的所有患者。排除周末手术和孤立的髂动脉瘤,以及有症状和破裂的表现。不符合规定的修复的直径阈值定义为:男性<55mm;女性<50mm,但髂直径不≥30mm。我们评估了术后影像学监测、报销金额、再干预、破裂和全因死亡率的依从性。我们将 EVAR 质量指标定义为:在索引手术中无转换为开放修复、5 年无破裂生存和符合最低影像学监测(术后 6 至 24 个月至少有一次计算机断层扫描记录)。
在 19018 例择期 EVAR 中,有 35%不符合 CPG 直径阈值(26%在阈值 5mm 以内)。不符合规定的修复率随时间增加(2003 年为 24%,2016 年为 36%;P<0.001)。接受不符合规定的修复的患者更年轻,合并症更少,更有可能符合使用说明的 EVAR(89%比 79%;P<0.001)。与符合 CPG 直径阈值的修复相比,接受不符合规定的修复的患者 5 年无再干预(86%比 81%;P<0.001)、无破裂生存(94%比 92%;P=0.01)和总生存率(71%比 61%;P<0.001)更高。尽管不符合规定的修复有更高的 1 年影像学监测率,但总体差异不大(68%比 65%;P=0.003)。重要的是,对于整个队列,随时间推移,随访影像学监测减少(2003 年为 93%,2014 年为 63%;P<0.001)。值得注意的是,尽管不符合规定的修复与符合规定的修复相比,复合质量指标的达标率更高(43%比 38%;P<0.001),但大多数修复都失败了。
SVS 认可的 CPG 直径阈值在择期 EVAR 中的符合率较差,且不符合规定的修复率呈上升趋势。不符合规定的修复似乎更常提供给合并症较少和解剖结构有利的患者,与符合 CPG 直径阈值的手术相比,这些修复与更高的再干预、破裂和生存率相关。重要的是,大多数情况下,不符合规定的修复都未能达到最低质量标准,这突显出需要进一步制定政策,以提高全国范围内 AAA 护理的整体质量和适当性。